In March 2025, the company declared new plans for any immediate-to-consumer supplying of its Wegovy weight loss drug. The company set up a completely new pharmacy, termed NovoCare, which might cost consumers $499 a month for usage of the drug, a lot less than half the expense of the drug by other pharmaceutical distribution networks.[53]In Oct 2024